An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...
Beta USA is sharpening its focus on brand visibility and rider engagement heading into 2026, announcing a new ambassador ...
Zacks Investment Research on MSN
AGIO's mitapivat gets FDA nod for thalassemia indication with REMS in label
Agios Pharmaceuticals AGIO announced that the FDA has approved Aqvesme (mitapivat) for the treatment of adult patients with ...
Google pushes Android 16 QPR3 Beta 1.1 to Pixel phones to address widespread app startup crashes, though some Microsoft apps fail.
The approval makes AQVESME the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, a rare blood disorder. The drug is expected ...
Google released QPR3 Beta 1.1. This hotfix stops apps from crashing on startup. Learn about new features and find the ...
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name in the U.S. for thalassemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback